Toxic metals and the menopause

Journal of the British Menopause Society

Volumn 10, Issue 2, 2004, Pages 60-64

  Vahter, Marie ^a   Berglund, Marika ^a   Åkesson, Agneta ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Cadmium; Lead; Menopause; Renal toxicity; Skeletal toxicity

Indexed keywords

CADMIUM; LEAD;

ADSORPTION KINETICS; BLOOD TOXICITY; CARDIOTOXICITY; CONCENTRATION (PARAMETERS); ENVIRONMENTAL EXPOSURE; FEMALE; FOOD CONTAMINATION; FOOD INTAKE; HUMAN; IRON STORAGE; MENOPAUSAL SYNDROME; MENOPAUSE; MENOPAUSE RELATED DISORDER; NEPHROTOXICITY; NEUROTOXICITY; OSTEOLYSIS; OSTEOMALACIA; OSTEOPOROSIS; RETROSPECTIVE STUDY; REVIEW; RICE; RISK ASSESSMENT; TOXICOKINETICS;

AGED; CADMIUM; ENVIRONMENTAL POLLUTION; FEMALE; FOLLOW-UP STUDIES; HUMANS; LEAD POISONING; MENOPAUSE; METALS; MIDDLE AGED; RISK ASSESSMENT; SWEDEN;

EID: 7744227589     PISSN: 13621807     EISSN: None     Source Type: Journal    
DOI: 10.1258/136218004774202364     Document Type: Review

References (60)

1. Vahter M, Berglund M, Akesson A, Liden C. Metals and women's health. Environ Res 2002; 88:145-155.
2. Roberts JS, Silbergeld EK. Pregnancy, lactation and menopause: how physiology and gender affect the toxicity of chemicals. Mt Sinai J Med 1995; 62: 343-355.
3. Silbergeld EK, Flaws JA. Chemicals and menopause: effects on age at menopause and on health status in the postmenopausal period. J Womens Health 1999; 8: 227-234.
4. Brett KM, Cooper GS. Associations with menopause and menopausal transition in a nationally representative US sample. Maturitas 2003; 45: 89-97.
5. Harlow BL, Signorello LB. Factors associated with early menopause. Maturitas 2000; 35: 3-9.
6. Zenzes MT. Smoking and reproduction: gene damage to human gametes and embryos. Hum Reprod Update 2000; 6: 122-131.
7. Hoyer PB, Sipes IG. Assessment of follicle destruction in chemical-induced ovarian toxicity. Annu Rev Pharmacol Toxicol 1996; 36: 307-331.
8. Borman SM, Christian PJ, Sipes IG, Hoyer PB. Ovotoxicity in female Fischer rats and B6 mice induced by low-dose exposure to three polycyclic aromatic hydrocarbons: comparison through calculation of an ovotoxic index. Toxicol Appl Pharmacol 2000; 167: 191-198.
9. Choe SY, Kim SJ, Kim HG, et al. Evaluation of estrogenicity of major heavy metals. Sci Total Environ 2003; 312: 15-21.
10. Kjellström T. Itai-itai disease. In: Friberg L, Elinder C, Kjellström T, Nordberg G, eds. Cadmium and health: A toxicological and epidemiological appraisal, pp 257-290. Boca Raton: CRC Press, 1986.
11. Matsuda T, Kobayashi E, Okubo Y, et al. Association between renal dysfunction and mortality among inhabitants in the region around the Jinzu River basin polluted by cadmium. Environ Res 2002; 88: 156-163.
12. Jarup L, Berglund M, Elinder CG, et al. Health effects of cadmium exposure - a review of the literature and a risk estimate. Scand J Work Environ Health 1998; 24 (Suppl) 1: 1-51.
13. Baecklund M, Pedersen NL, Bjorkman L, Vahter M. Variation in blood concentrations of cadmium and lead in the elderly. Environ Res 1999; 80: 222-230.
14. Berglund M, Akesson A, Nermell B, Vahter M. Intestinal absorption of dietary cadmium in women depends on body iron stores and fiber intake. Environ Health Perspect 1994; 102: 1058-1066.
15. Gunshin H, Mackenzie B, Berger UV, et al. Cloning and characterization of a mammalian proton-coupled metal-ion transporter. Nature 1997; 388: 482-488.
16. Akesson A, Berglund M, Schutz A, et al. Cadmium exposure in pregnancy and lactation in relation to iron status. Am J Public Health 2002; 92: 284-287.
17. Bjorkman L, Vahter M, Pedersen NL. Both the environment and genes are important for concentrations of cadmium and lead in blood. Environ Health Perspect 2000; 108: 719-722.
18. Jarup L, Hellstrom L, Alfven T, et al. Low level exposure to cadmium and early kidney damage: the OSCAR study. Occup Environ Med 2000; 57: 668-672.
19. Suwazono Y, Kobayashi E, Okubo Y, et al. Renal effects of cadmium exposure in cadmium nonpolluted areas in Japan. Environ Res 2000; 84: 44-55.
20. Noonan CW, Sarasua SM, Campagna D, et al. Effects of exposure to low levels of environmental cadmium on renal biomarkers. Environ Health Perspect 2002; 110: 151-155.
21. Buchet JP, Heilier JF, Bernard A, et al. Urinary protein excretion in humans exposed to arsenic and cadmium. Int Arch Occup Environ Health 2003; 76: 111-120.
22. Yamanaka O, Kobayashi E, Nogawa K, et al. Association between renal effects and cadmium exposure in cadmium-nonpolluted area in Japan. Environ Res 1998; 77: 1-8.
23. Hellstrom L, Elinder CG, Dahlberg B, et al. Cadmium exposure and end-stage renal disease. Am J Kidney Dis 2001; 38: 1001-1008.
24. Alfven T, Elinder CG, Carlsson MD, et al. Low-level cadmium exposure and osteoporosis. J Bone Miner Res 2000; 15: 1579-1586.
25. Staessen JA, Roels HA, Emelianov D, et al. Environmental exposure to cadmium, forearm bone density, and risk of fractures: prospective population study. Public Health and Environmental Exposure to Cadmium (PheeCad) Study Group. Lancet 1999; 353: 1140-1144.
26. Tsuritani I, Honda R, Ishizaki M, et al. Impairment of vitamin D metabolism due to environmental cadmium exposure, and possible relevance to sex-related differences in vulnerability to the bone damage. J Toxicol Environ Health 1992; 37: 519-533.
27. Tsuritani I, Honda R, Ishizaki M, et al. Serum bone-type alkaline phosphatase activity in women living in a cadmium-polluted area. Toxicol Lett 1994; 71: 209-216.
28. Berglund M, Akesson A, Bjellerup P, Vahter M. Metal-bone interactions. Toxicol Lett 2000; 112-113: 219-225.
29. Wilson AK, Cerny EA, Smith BD, et al. Effects of cadmium on osteoclast formation and activity in vitro. Toxicol Appl Pharmacol 1996; 140: 451-460.
30. Uriu K, Morimoto I, Kai K, et al. Uncoupling between bone formation and resorption in ovariectomized rats with chronic cadmium exposure. Toxicol Appl Pharmacol 2000; 164: 264-272.
31. Regunathan A, Glesne DA, Wilson AK, et al. Microarray analysis of changes in bone cell gene expression early after cadmium gavage in mice. Toxicol Appl Pharmacol 2003; 191: 272-293.
32. Sacco-Gibson N, Chaudhry S, Brock A, et al. Cadmium effects on bone metabolism: accelerated resorption in ovariectomized, aged beagles. Toxicol Appl Pharmacol 1992; 113: 274-283.
33. Garcia-Morales P, Saceda M, Kenney N, et al. Effect of cadmium on estrogen receptor levels and estrogen-induced responses in human breast cancer cells. J Biol Chem 1994; 269: 16896-16901.
34. Stoica A, Katzenellenbogen BS, Martin MB. Activation of estrogen receptor-alpha by the heavy metal cadmium. Mol Endocrinol 2000; 14: 545-553.
35. Johnson MD, Kenney N, Stoica A, et al. Cadmium mimics the in vivo effects of estrogen in the uterus and mammary gland. Nat Med 2003; 9: 1081-1084.
36. Petersson Grawe K, Oskarsson A. Cadmium in milk and mammary gland in rats and mice. Arch Toxicol 2000; 73: 519-527.
37. WHO. Environmental health criteria 165. Inorganic lead. Geneva: World Health Organization, 1995.
38. Stromberg U, Lundh T, Schütz A, Skerfving S. Yearly measurements of blood lead in Swedish children since 1978: an update focusing on the petrol lead free period 1995-2001. Occup Environ Med 2003; 60: 370-372.
39. Vahter M, Berglund M, Lind B, et al. Personal monitoring of lead and cadmium exposure - a Swedish study with special reference to methodological aspects. Scand J Work Environ Health 1991; 17: 65-74.
40. Kelada S, Shelton E, Kaufmann R, Khoury M. Delta-aminolevulinic acid dehydratase genotype and lead toxicity: a HuGE review. Am J Epidemiol 2001; 154: 1-13.
41. Hu H, Wu M, Cheng Y, et al. The delta-aminolevulinic acid dehydratase (ALAD) polymorphism and bone and blood lead levels in community-exposed men: the Normative Aging Study. Environ Health Perspect 2001; 109: 827-832.
42. Pounds JG, Long GJ, Rosen JF. Cellular and molecular toxicity of lead in bone. Environ Health Perspect 1991; 91: 17-32.
43. Tellez-Rojo M, Hernandez-Avila M, Gonzales-Cossio T, et al. Impact of breastfeeding on the mobilization of lead from bone. Am J Epidemiol 2002; 155: 420-428.
44. Hernandez-Avila M, Gonzales-Cossio T, Hernandez-Avila J, et al. Dietary calcium supplements to lower blood lead levels in lactating women; a randomized placebo-controlled trial. Epidemiology 2003; 14: 206-212.
45. Silbergeld EK, Schwartz J, Mahaffey K. Lead and osteoporosis: mobilization of lead from bone in postmenopausal women. Environ Res 1988; 47: 79-94.
46. Symanski E, Hertz-Picciotto I. Blood lead levels in relation to menopause, smoking and pregnancy history. Am J Epidemiol 1995; 141: 1047-1058.
47. Hernandez-Avila M, Villalpando CG, Palazuelos E, et al. Determinants of blood lead levels across the menopausal transition. Arch Environ Health 2000; 55: 355-360.
48. Garrido Latorre F, Hernandez-Avila M, Orozco J, et al. Relationship of blood and bone lead to menopause and bone mineral density among middle-age women in Mexico City. Environ Health Perspect 2003; 111: 631-636.
49. Webber C, Chettle D, Bowins R, et al. Hormone replacement therapy may reduce the return of endogenous lead from bone to the circulation. Environ Health Perspect 1995; 103: 1150-1153.
50. Gulson B, Mizon K, Smith H, et al. Skeletal lead release during bone resorption; Effect of bisphosphonate treatment in a pilot study. Environ Health Perspect 2002; 110: 1017-1023.
51. Dowd T, Rosen J, Mints L, Gundberg C. The effect of Pb2+ on the structure and hydroxyapatite binding properties of osteocalcin. Biochimica et Biophysica Acta 2001; 1535: 153-163.
52. Alfven T, Jarup L, Elinder CG. Cadmium and lead in blood in relation to low bone mineral density and tubular proteinuria. Environ Health Perspect 2002; 110: 699-702.
53. Weaver V, Schwartz B, Ahn K, et al. Associations of renal function with polymorphisms in the delta-aminolevulinic acid dehydratase, vitamin D receptor, and nitric oxide synthase genes in Korean lead workers. Environ Health Perspect 2003; 111: 1613-1619.
54. Wu M, Kelsey K, Schwartz J, et al. A delta-aminolevulinic acid dehydratase (ALAD) polymorphism may modify the relationship of low-level lead exposure to uricemia and renal function: the normative aging study. Environ Health Perspect 2003; 111: 335-341.
55. Schwartz BS, Stewart WF, Bolla KI, et al. Past adult lead exposure is associated with longitudinal decline in cognitive function. Neurology 2000; 55: 1144-1150.
56. Payton M, Riggs KM, Spiro A, et al. Relations of bone and blood lead to cognitive function: the VA Normative Aging Study. Neurotoxicol Teratol 1998; 20: 19-27.
57. Muldoon SB, Cauley JA, Kuller LH, et al. Effects of blood lead levels on cognitive function of older women. Neuroepidemiology 1996; 15: 62-72.
58. Vig E, Hu H. Lead toxicity in older adults. J Am Geriatr Soc 2000; 48: 1501-1506.
59. Rothenberg SJ, Kondrashov V, Manalo M, et al. Increases in hypertension and blood pressure during pregnancy with increased bone lead levels. Am J Epidemiol 2002; 156: 1079-1087.
60. Nash D, Magder L, Lustberg M, et al. Blood lead, blood pressure, and hypertension in perimenopausal and postmenopausal women. JAMA 2003; 289: 1523-1532.